Search
Neuroborreliosis, Borrelia Burgdorferi
go.drugbank.com/conditions/DBCOND0078182Drugs: CeftriaxoneSynonyms: Infection due to Borrelia burgdorferi sensu latoCalcium chloride
go.drugbank.com/drugs/DB01164ApprovedInvestigationalIt can be produced directly from limestone, but large amounts are also produced as a by-product of the Solvay process. Because of its hygroscopic nature, it must be kept in tightly-sealed containers.
Mixtures: SOLUCION RINGER NO.3, Hemosol LoGlycogen Storage Disease Type II
go.drugbank.com/conditions/DBCOND0002595Synonyms: Glycogenosis due to acid maltase deficiency, Glycogen storage disease due to acid maltase deficiency (disorder)Beta carotene
go.drugbank.com/drugs/DB06755ApprovedNutraceutical[T162] It is the most abundant form of carotenoid and it is a precursor of the vitamin A. Beta-carotene is composed of two retinyl groups. … Beta-carotene, with the molecular formula C40H56, belongs to the group of carotenoids consisting of isoprene units.
Mixtures: TL-Folate, Multi Nt-OXGuanethidine
go.drugbank.com/drugs/DB01170ApprovedWithdrawnIt is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues. … An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves.
Synonyms: 2-(1-N,N-Heptamethyleneimino)ethylguanidine, N-(2-Perhydroazocin-1-ylethyl)guanidineDextrose, unspecified form
go.drugbank.com/drugs/DB09341ApprovedInvestigationalVet approvedIt is primarily stored as starch in plants and glycogen in animals to be used in various metabolic processes in the cellular level. … The unspecified form of glucose is commonly supplied as an injection for nutritional supplementation or metabolic disorders where glucose levels are improperly regulated.
Mixtures: DEXTROSE 5% IN NS 0.9% INJ 1000ML, SmofKabiven N-Plus zentral Emulsion zur InfusionSynonyms: Dextrose, unspecified formPibrentasvir
go.drugbank.com/drugs/DB13878ApprovedInvestigationalThe ultimate goal of the combination treatment is to achieve sustained virologic response (SVR) and cure the patients from the infection. … In combination with [DB13879], pibrentastiv is a useful therapy for patients who experienced therapeutic failure from other NS5A inhibitors.
CX-052075
go.drugbank.com/drugs/DB31655Approved[L53408,L53423] The original approval was formulated with the JN.1 strain ([mRNA-1283]), but was ultimately updated to the sublineage LP.8.1.[L54586] … [L53413,A274083] mNEXSPIKE was approved by the US FDA in June 2025 for use in patients who have been previously vaccinated with any COVID-19 vaccine and who are at a higher risk of severe outcomes from
Factor XIII (human)
go.drugbank.com/drugs/DB12909ApprovedInvestigationalAs a result, the active transglutaminase from subunit A cross-links fibrin and other proteins resulting in increased mechanical strength and resistance to fibrinolysis of the fibrin clot. … When activated by thrombin at the site of injury, the FXIII pro-enzyme is cleaved resulting in activation of the catalytic A-subunit and dissociation from its carrier B-subunit.
Urea C-13
go.drugbank.com/drugs/DB09510ApprovedInvestigationalTo detect H. pylori, urea labeled with 13C is swallowed by the patient. … If gastric urease from H. pylori is present, urea is split to form CO2 and NH3 at the interface between the gastric epithelium and lumen and 13CO2 is absorbed into the blood and exhaled in the breath.